ASTRAZENECA PLC
AZNCFDrugs in Pipeline
205
Phase 3 Programs
138
Upcoming Catalysts
7
Next Catalyst
May 1, 2026
6wMarket Overview
Stock performance and key metrics
7 upcoming, 1 past
Aclidinium Bromide/Formoterol Fumarate
Chronic Obstructive Pulmonary Disease (COPD)
Duloxetine
Major Depressive Disorder
Olaparib 300mg tablets
Newly Diagnosed
MEDI4736 (Durvalumab)+Tremelimumab
Non-Small-Cell Lung Carcinoma NSCLC
AZD0585
Hypertriglyceridemia
Gefitinib or Docetaxel
Non-Small Cell Lung Cancer
Rosuvastatin
Aortic Stenosis
R-mini-CHOP
Large B-cell Lymphoma
MEDI4736
Ovarian
D961H sachet 10 mg
Gastric Ulcer (GU)
Chlorambucil
Untreated Chronic Lymphocytic Leukemia
Esomeprazole
NSAIDs
Volrustomig
Unresectable Pleural Mesothelioma
Docetaxel
Non-Small-Cell Lung Carcinoma
Acalabrutinib
Phase I: Relapsed or Refractory B-cell Malignancies
BFF MDI 160/9.6 μg BID (320/19.2μg/day)
Asthma
Osimertinib
Non-Small Cell Lung Cancer
Durvalumab + Chemotherapy phase
Advanced or Recurrent Endometrial Cancer
Anastozole (Arimidex)
Breast Cancer
pioglitazone
Type 2 Diabetes Mellitus
Prednisolone
Chronic Obstructive Pulmonary Disease
insulin detemir
Type 2 Diabetes Mellitus
HFA MDI
Asthma
Formoterol Fumarate
Chronic Obstructive Pulmonary Disease
Experimental: Tralokinumab
Uncontrolled Asthma
Nab-paclitaxel
Non-small Cell Lung Cancer
Esomeprazole (Nexium)
Gastroesophageal Reflux Disease (GERD)
Durvalumab +Tremelimumab
Non Small Cell Lung Carcinoma NSCLC
Durvalumab (MEDI4736)
Non Small Cell Lung Carcinoma NSCLC
BGF MDI 320/14.4/9.6 μg
COPD (Chronic Obstructive Pulmonary Disease)
Salbutamol
COPD
Durvalumab
Hepatocellular Carcinoma
Dato-DXd
Metastatic Non-small Cell Lung Cancer
Exenatide Once Weekly
Type 2 Diabetes Mellitus
Cisplatin
Non-Small Cell Lung Cancer
TC-5214
Major Depressive Disorder
Fluticasone propionate
Seasonal Allergic Rhinitis
Gefitinib
NSCLC
Atorvastatin
Hypercholesterolaemia
olaparib
Colorectal Cancer
Open Label Run In Esomeprazole
Gastroesophageal Reflux Disease (GERD)
Baxdrostat
Primary Hyperaldosteronism
exenatide twice daily
Type 2 Diabetes Mellitus
Benralizumab 30 mg SC + Mometasone Furoate
Nasal Polyposis
NXY-059
Cerebral Stroke
Sodium Zirconium Cyclosilicate 5g
Hyperkalemia
Dapagliflozin
Type 2 Diabetes Mellitus
Metoprolol Succinate
High Blood Pressure (Hypertension).
Fulvestrant
Advanced Breast Cancer
Datopotamab Deruxtecan
Non-Small Cell Lung Cancer
Exenatide once weekly suspension
Diabetes Type 2
Capivasertib
Triple Negative Breast Neoplasms
Ciclesonide Nasal Spray
Rhinitis, Allergic, Seasonal
Tezepelumab
Asthma
Ciclesonide
Asthma
Nirsevimab
Lower Respiratory Tract Infection
Experimental: Tezepelumab
Asthma
formoterol
Stable Asthma
Capecitabine
Breast Cancer
Quetiapine Extended Release
Schizophrenia
Tremelimumab
Non Small Cell Lung Cancer NSCLC
enzalutamide
Metastatic Castration-resistant Prostate Cancer
Dapagliflozin 10 mg
Type 2 Diabetes Mellitus
Ticagrelor 90 mg
Myocardial Infarction
Aclidinium bromide/formoterol Fixed-Dose Combination
COPD
Gemcitabine
Urothelial Cancer
Pravastatin
Hypercholesterolemia
budesonide/formoterol (Symbicort)
Mild or Moderate Asthma
Seroquel SR
Schizophrenia
NKTR-118
Opioid-Induced Constipation (OIC)
Saxagliptin
Type 2 Diabetes
fluticasone/salmeterol
Asthma
Benralizumab
Asthma
Omeprazole
Non-erosive Reflux Disease
Metformin IR
Diabetes Mellitus, Type 2
Terbutaline Turbuhaler
Asthma
exenatide
Type 2 Diabetes Mellitus
Paroxetine
Generalized Anxiety Disorder
Anifrolumab
Active Systemic Lupus Erythematosus
Lithium
Mania
BGF MDI 320/28.8/9.6 μg
Asthma
Etoposide
Non-small Cell Lung Cancer
Baxdrostat/dapagliflozin
Chronic Kidney Disease and Hypertension
Quetiapine
Psychotic Disorders
AC2993
Diabetes Mellitus, Non-Insulin-Dependent
fostamatinib
Rheumatoid Arthritis
Anastrozole
Breast Neoplasms
Pemetrexed
NSCLC
Bicalutamide
Prostate Cancer
Quetiapine Fumarate (SEROQUEL) Extended Release
Bipolar Depression
Symbicort, used twice daily (b.i.d) and as needed (prn)
Asthma
Camizestrant
Breast Cancer, Early Breast Cancer
budesonide
Asthma
budesonide/formoterol
Asthma
Quetiapine fumarate
Schizophrenia
Tamoxifen
Bone Density
Budesonide Turbuhaler (Pulmicort)
Asthma
Saruparib
Metastatic Castration-Sensitive Prostate Cancer
Symbicort Turbuhaler
Asthma
Paclitaxel
Metastatic Breast Cancer
Quetiapine XR
Schizophrenic Disorders
Erlotinib 150/100 mg
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
Candesartan
Congestive Heart Failure
Puxitatug Samrotecan
Endometrial Cancer
Ticagrelor
Peripheral Artery Disease
Symbicort pMDI
Asthma
Rosuvastatin calcium
Coronary Arteriosclerosis
pramlintide acetate
Overweight
BDA MDI HFO 160/180 μg
Asthma
Rilvegostomig
Biliary Tract Cancer
Roflumilast
Asthma
abiraterone acetate
Metastatic Castration-resistant Prostate Cancer
Symbicort
Asthma
Budesonide/formoterol (Symbicort Turbuhaler)
Chronic Obstructive Pulmonary Disease
Domvanalimab
Non-Small Cell Lung Cancer
75mg selumetinib
Metastatic
glimepiride
Type 2 Diabetes Mellitus
Tralokinumab
Asthma
Selumetinib
Neurofibromatosis 1
metformin
Type 2 Diabetes Mellitus
Budesonide/formoterol Turbuhaler
Asthma
candesartan cilexetil
Type 1 Diabetes
dacarbazine
Melanoma
AZD9291 80 mg/40 mg
Stage IB-IIIA Non-small Cell Lung Carcinoma
AZD0780
Cardiovascular Disease
AZD7442
COVID-19
savolitinib
Carcinoma
MEDI4736 (Durvalumab)
Advanced Solid Malignancies
Sunitinib
Carcinoma
sitagliptin
Type 2 Diabetes
Carboplatin
Endometrial Cancer
Tozorakimab
Asthma
Ropivacaine
Anesthesia,Spinal
Metformin XR
Type 2 Diabetes
AZD0486
B-cell Acute Lymphoblastic Leukemia (B-ALL)
methotrexate
Squamous Cell Carcinoma of the Head and Neck
Rosuvastatin 20mg
Homozygous Familial Hypercholesterolemia (HoFH)
Aclidinium bromide
Chronic Obstructive Pulmonary Disease
AZD9567
Rheumatoid Arthritis
AZD9833
Advanced ER-Positive HER2-Negative Breast Cancer
Tomudex
Inoperable or Recurrent Rectal Cancer
AZD7798
Moderate to Severe Crohn's Disease
AZD7624 1.0 mg
Chronic Obstructive Pulmonary Disease COPD
Tesaglitazar
Type 2 Diabetes
ZD4054
Non Small Cell Lung Cancer
Aclidinium bromide and formoterol
Chronic Obstructive Pulmonary Disease (COPD)
Cediranib
Renal Cell Carcinoma
MEDI3506
Diabetic Kidney Disease
AZD4635
Progressive Metastatic Castrate-Resistant Prostate Cancer
Selumetinib+Docetaxel
Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)
AZD0901
Gastric Cancer
CP-675,206
Carcinoma, Non-small-cell Lung
RDEA3170
Gout and Asymptomatic Hyperuricemia
AZD5863
Gastric Cancer
AZD3632
Acute Lymphoblastic Leukaemia
Adavosertib
Uterine Serous Carcinoma
AZD8233
Dyslipidaemia
AZD0516
Metastatic Prostate Cancer
AZD6234
Endocrinology
Datopotamab Deruxtecan (Dato-DXd)
Carcinoma, Non-Small-Cell Lung
exenatide once monthly suspension
Type 2 Diabetes
Amivantamab
Non-Small Cell Lung Cancer (NSCLC)
Zibotentan
Chronic Kidney Disease
AZD5672
Rheumatoid Arthritis
Zibotentan + dapagliflozin
Liver Cirrhosis
tralokinumab cohort 1
Idiopathic Pulmonary Fibrosis
Anastrazole
Breast Cancer
AZD2811
Small-Cell Lung Cancer
AZD7268
Major Depressive Disorder
Quetiapine fumarate (Seroquel)
Major Depressive Disorder
AZD5305
Metastatic Prostate Cancer
AZD1236
Chronic Obstructive Pulmonary Disease
AZD3480
Alzheimer Disease
AZD0292
Bronchiectasis With Pseudomonas Aeruginosa Colonization
AZD6765
Depression
AZD9550
Obesity or Overweight
AZD4547
FGFR Inhibition, Pharmacokinetics, Biomarkers
AZD5423
Asthma
AZD5148
Clostridioides Difficile Infection
AZD1981
Chronic Obstructive Pulmonary Disease
AZD7325
Anxiety Disorders
Verinurad
Heart Failure With Preserved Ejection Fraction (HFpEF)
MEDI0382 100 μg
Type 2 Diabetes
AZD5004
Obesity or Overweight
AZD2171
Gastrointestinal Stromal Tumors
AZD9291
Non-Small Cell Lung Cancer
AZD6244
Metastatic Colorectal Cancer
AZD1305
Left Ventricle Function
AZD3355
Reflux Episodes
AZD4831
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
MEDI-546
Systemic Lupus Erythematosus
AZD4604
Asthma
Ciclesonide HFA
Rhinitis, Allergic, Seasonal
AZD4877
Bladder Cancer
AZD9773
Severe Sepsis
AZD0305
Multiple Myeloma
AZD1656
Type II Diabetes
CIN-107 2 mg dosing
Primary Aldosteronism
AZD2423
Chronic Obstructive Pulmonary Disease
AZD2066
Pain
AZD4573
Relapsed/Refractory Peripheral T-cell Lymphoma
[18F]AZD4694
Alzheimer's Disease
CP-675,206 (Tremelimumab)
Colorectal Neoplasms
AZD1222
COVID-19
AZD9668
Chronic Obstructive Pulmonary Disease (COPD)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Aclidinium Bromide/Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Duloxetine | Phase 3 | Major Depressive Disorder | - | - |
Olaparib 300mg tablets | Phase 3 | Newly Diagnosed | - | - |
MEDI4736 (Durvalumab)+Tremelimumab | Phase 3 | Non-Small-Cell Lung Carcinoma NSCLC | - | - |
AZD0585 | Phase 3 | Hypertriglyceridemia | - | - |
Gefitinib or Docetaxel | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Rosuvastatin | Phase 3 | Aortic Stenosis | - | - |
R-mini-CHOP | Phase 3 | Large B-cell Lymphoma | - | - |
MEDI4736 | Phase 3 | Ovarian | - | - |
D961H sachet 10 mg | Phase 3 | Gastric Ulcer (GU) | - | - |
Chlorambucil | Phase 3 | Untreated Chronic Lymphocytic Leukemia | - | - |
Esomeprazole | Phase 3 | NSAIDs | - | - |
Volrustomig | Phase 3 | Unresectable Pleural Mesothelioma | - | - |
Docetaxel | Phase 3 | Non-Small-Cell Lung Carcinoma | - | - |
Acalabrutinib | Phase 3 | Phase I: Relapsed or Refractory B-cell Malignancies | - | - |
BFF MDI 160/9.6 μg BID (320/19.2μg/day) | Phase 3 | Asthma | - | - |
Osimertinib | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Durvalumab + Chemotherapy phase | Phase 3 | Advanced or Recurrent Endometrial Cancer | - | - |
Anastozole (Arimidex) | Phase 3 | Breast Cancer | - | - |
pioglitazone | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Prednisolone | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
insulin detemir | Phase 3 | Type 2 Diabetes Mellitus | - | - |
HFA MDI | Phase 3 | Asthma | - | - |
Formoterol Fumarate | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Experimental: Tralokinumab | Phase 3 | Uncontrolled Asthma | - | - |
Nab-paclitaxel | Phase 3 | Non-small Cell Lung Cancer | - | - |
Esomeprazole (Nexium) | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
Durvalumab +Tremelimumab | Phase 3 | Non Small Cell Lung Carcinoma NSCLC | - | - |
Durvalumab (MEDI4736) | Phase 3 | Non Small Cell Lung Carcinoma NSCLC | - | - |
BGF MDI 320/14.4/9.6 μg | Phase 3 | COPD (Chronic Obstructive Pulmonary Disease) | - | - |
Salbutamol | Phase 3 | COPD | - | - |
Durvalumab | Phase 3 | Hepatocellular Carcinoma | - | - |
Dato-DXd | Phase 3 | Metastatic Non-small Cell Lung Cancer | - | - |
Exenatide Once Weekly | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Cisplatin | Phase 3 | Non-Small Cell Lung Cancer | - | - |
TC-5214 | Phase 3 | Major Depressive Disorder | - | - |
Fluticasone propionate | Phase 3 | Seasonal Allergic Rhinitis | - | - |
Gefitinib | Phase 3 | NSCLC | - | - |
Atorvastatin | Phase 3 | Hypercholesterolaemia | - | - |
olaparib | Phase 3 | Colorectal Cancer | - | - |
Open Label Run In Esomeprazole | Phase 3 | Gastroesophageal Reflux Disease (GERD) | - | - |
Baxdrostat | Phase 3 | Primary Hyperaldosteronism | - | - |
exenatide twice daily | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Benralizumab 30 mg SC + Mometasone Furoate | Phase 3 | Nasal Polyposis | - | - |
NXY-059 | Phase 3 | Cerebral Stroke | - | - |
Sodium Zirconium Cyclosilicate 5g | Phase 3 | Hyperkalemia | - | - |
Dapagliflozin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Metoprolol Succinate | Phase 3 | High Blood Pressure (Hypertension). | - | - |
Fulvestrant | Phase 3 | Advanced Breast Cancer | - | - |
Datopotamab Deruxtecan | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Exenatide once weekly suspension | Phase 3 | Diabetes Type 2 | - | - |
Capivasertib | Phase 3 | Triple Negative Breast Neoplasms | - | - |
Ciclesonide Nasal Spray | Phase 3 | Rhinitis, Allergic, Seasonal | - | - |
Tezepelumab | Phase 3 | Asthma | - | - |
Ciclesonide | Phase 3 | Asthma | - | - |
Nirsevimab | Phase 3 | Lower Respiratory Tract Infection | - | - |
Experimental: Tezepelumab | Phase 3 | Asthma | - | - |
formoterol | Phase 3 | Stable Asthma | - | - |
Capecitabine | Phase 3 | Breast Cancer | - | - |
Quetiapine Extended Release | Phase 3 | Schizophrenia | - | - |
Tremelimumab | Phase 3 | Non Small Cell Lung Cancer NSCLC | - | - |
enzalutamide | Phase 3 | Metastatic Castration-resistant Prostate Cancer | - | - |
Dapagliflozin 10 mg | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Ticagrelor 90 mg | Phase 3 | Myocardial Infarction | - | - |
Aclidinium bromide/formoterol Fixed-Dose Combination | Phase 3 | COPD | - | - |
Gemcitabine | Phase 3 | Urothelial Cancer | - | - |
Pravastatin | Phase 3 | Hypercholesterolemia | - | - |
budesonide/formoterol (Symbicort) | Phase 3 | Mild or Moderate Asthma | - | - |
Seroquel SR | Phase 3 | Schizophrenia | - | - |
NKTR-118 | Phase 3 | Opioid-Induced Constipation (OIC) | - | - |
Saxagliptin | Phase 3 | Type 2 Diabetes | - | - |
fluticasone/salmeterol | Phase 3 | Asthma | - | - |
Benralizumab | Phase 3 | Asthma | - | - |
Omeprazole | Phase 3 | Non-erosive Reflux Disease | - | - |
Metformin IR | Phase 3 | Diabetes Mellitus, Type 2 | - | - |
Terbutaline Turbuhaler | Phase 3 | Asthma | - | - |
exenatide | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Paroxetine | Phase 3 | Generalized Anxiety Disorder | - | - |
Anifrolumab | Phase 3 | Active Systemic Lupus Erythematosus | - | - |
Lithium | Phase 3 | Mania | - | - |
BGF MDI 320/28.8/9.6 μg | Phase 3 | Asthma | - | - |
Etoposide | Phase 3 | Non-small Cell Lung Cancer | - | - |
Baxdrostat/dapagliflozin | Phase 3 | Chronic Kidney Disease and Hypertension | - | - |
Quetiapine | Phase 3 | Psychotic Disorders | - | - |
AC2993 | Phase 3 | Diabetes Mellitus, Non-Insulin-Dependent | - | - |
fostamatinib | Phase 3 | Rheumatoid Arthritis | - | - |
Anastrozole | Phase 3 | Breast Neoplasms | - | - |
Pemetrexed | Phase 3 | NSCLC | - | - |
Bicalutamide | Phase 3 | Prostate Cancer | - | - |
Quetiapine Fumarate (SEROQUEL) Extended Release | Phase 3 | Bipolar Depression | - | - |
Symbicort, used twice daily (b.i.d) and as needed (prn) | Phase 3 | Asthma | - | - |
Camizestrant | Phase 3 | Breast Cancer, Early Breast Cancer | - | - |
budesonide | Phase 3 | Asthma | - | - |
budesonide/formoterol | Phase 3 | Asthma | - | - |
Quetiapine fumarate | Phase 3 | Schizophrenia | - | - |
Tamoxifen | Phase 3 | Bone Density | - | - |
Budesonide Turbuhaler (Pulmicort) | Phase 3 | Asthma | - | - |
Saruparib | Phase 3 | Metastatic Castration-Sensitive Prostate Cancer | - | - |
Symbicort Turbuhaler | Phase 3 | Asthma | - | - |
Paclitaxel | Phase 3 | Metastatic Breast Cancer | - | - |
Quetiapine XR | Phase 3 | Schizophrenic Disorders | - | - |
Erlotinib 150/100 mg | Phase 3 | Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer | - | - |
Candesartan | Phase 3 | Congestive Heart Failure | - | - |
Puxitatug Samrotecan | Phase 3 | Endometrial Cancer | - | - |
Ticagrelor | Phase 3 | Peripheral Artery Disease | - | - |
Symbicort pMDI | Phase 3 | Asthma | - | - |
Rosuvastatin calcium | Phase 3 | Coronary Arteriosclerosis | - | - |
pramlintide acetate | Phase 3 | Overweight | - | - |
BDA MDI HFO 160/180 μg | Phase 3 | Asthma | - | - |
Rilvegostomig | Phase 3 | Biliary Tract Cancer | - | - |
Roflumilast | Phase 3 | Asthma | - | - |
abiraterone acetate | Phase 3 | Metastatic Castration-resistant Prostate Cancer | - | - |
Symbicort | Phase 3 | Asthma | - | - |
Budesonide/formoterol (Symbicort Turbuhaler) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
Domvanalimab | Phase 3 | Non-Small Cell Lung Cancer | - | - |
75mg selumetinib | Phase 3 | Metastatic | - | - |
glimepiride | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Tralokinumab | Phase 3 | Asthma | - | - |
Selumetinib | Phase 3 | Neurofibromatosis 1 | - | - |
metformin | Phase 3 | Type 2 Diabetes Mellitus | - | - |
Budesonide/formoterol Turbuhaler | Phase 3 | Asthma | - | - |
candesartan cilexetil | Phase 3 | Type 1 Diabetes | - | - |
dacarbazine | Phase 3 | Melanoma | - | - |
AZD9291 80 mg/40 mg | Phase 3 | Stage IB-IIIA Non-small Cell Lung Carcinoma | - | - |
AZD0780 | Phase 3 | Cardiovascular Disease | - | - |
AZD7442 | Phase 3 | COVID-19 | - | - |
savolitinib | Phase 3 | Carcinoma | - | - |
MEDI4736 (Durvalumab) | Phase 3 | Advanced Solid Malignancies | - | - |
Sunitinib | Phase 3 | Carcinoma | - | - |
sitagliptin | Phase 3 | Type 2 Diabetes | - | - |
Carboplatin | Phase 3 | Endometrial Cancer | - | - |
Tozorakimab | Phase 3 | Asthma | - | - |
Ropivacaine | Phase 3 | Anesthesia,Spinal | - | - |
Metformin XR | Phase 3 | Type 2 Diabetes | - | - |
AZD0486 | Phase 3 | B-cell Acute Lymphoblastic Leukemia (B-ALL) | - | - |
methotrexate | Phase 3 | Squamous Cell Carcinoma of the Head and Neck | - | - |
Rosuvastatin 20mg | Phase 3 | Homozygous Familial Hypercholesterolemia (HoFH) | - | - |
Aclidinium bromide | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
AZD9567 | Phase 2 | Rheumatoid Arthritis | - | - |
AZD9833 | Phase 2 | Advanced ER-Positive HER2-Negative Breast Cancer | - | - |
Tomudex | Phase 2 | Inoperable or Recurrent Rectal Cancer | - | - |
AZD7798 | Phase 2 | Moderate to Severe Crohn's Disease | - | - |
AZD7624 1.0 mg | Phase 2 | Chronic Obstructive Pulmonary Disease COPD | - | - |
Tesaglitazar | Phase 2 | Type 2 Diabetes | - | - |
ZD4054 | Phase 2 | Non Small Cell Lung Cancer | - | - |
Aclidinium bromide and formoterol | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |
Cediranib | Phase 2 | Renal Cell Carcinoma | - | - |
MEDI3506 | Phase 2 | Diabetic Kidney Disease | - | - |
AZD4635 | Phase 2 | Progressive Metastatic Castrate-Resistant Prostate Cancer | - | - |
Selumetinib+Docetaxel | Phase 2 | Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) | - | - |
AZD0901 | Phase 2 | Gastric Cancer | - | - |
CP-675,206 | Phase 2 | Carcinoma, Non-small-cell Lung | - | - |
RDEA3170 | Phase 2 | Gout and Asymptomatic Hyperuricemia | - | - |
AZD5863 | Phase 2 | Gastric Cancer | - | - |
AZD3632 | Phase 2 | Acute Lymphoblastic Leukaemia | - | - |
Adavosertib | Phase 2 | Uterine Serous Carcinoma | - | - |
AZD8233 | Phase 2 | Dyslipidaemia | - | - |
AZD0516 | Phase 2 | Metastatic Prostate Cancer | - | - |
AZD6234 | Phase 2 | Endocrinology | - | - |
Datopotamab Deruxtecan (Dato-DXd) | Phase 2 | Carcinoma, Non-Small-Cell Lung | - | - |
exenatide once monthly suspension | Phase 2 | Type 2 Diabetes | - | - |
Amivantamab | Phase 2 | Non-Small Cell Lung Cancer (NSCLC) | - | - |
Zibotentan | Phase 2 | Chronic Kidney Disease | - | - |
AZD5672 | Phase 2 | Rheumatoid Arthritis | - | - |
Zibotentan + dapagliflozin | Phase 2 | Liver Cirrhosis | - | - |
tralokinumab cohort 1 | Phase 2 | Idiopathic Pulmonary Fibrosis | - | - |
Anastrazole | Phase 2 | Breast Cancer | - | - |
AZD2811 | Phase 2 | Small-Cell Lung Cancer | - | - |
AZD7268 | Phase 2 | Major Depressive Disorder | - | - |
Quetiapine fumarate (Seroquel) | Phase 2 | Major Depressive Disorder | - | - |
AZD5305 | Phase 2 | Metastatic Prostate Cancer | - | - |
AZD1236 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD3480 | Phase 2 | Alzheimer Disease | - | - |
AZD0292 | Phase 2 | Bronchiectasis With Pseudomonas Aeruginosa Colonization | - | - |
AZD6765 | Phase 2 | Depression | - | - |
AZD9550 | Phase 2 | Obesity or Overweight | - | - |
AZD4547 | Phase 2 | FGFR Inhibition, Pharmacokinetics, Biomarkers | - | - |
AZD5423 | Phase 2 | Asthma | - | - |
AZD5148 | Phase 2 | Clostridioides Difficile Infection | - | - |
AZD1981 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD7325 | Phase 2 | Anxiety Disorders | - | - |
Verinurad | Phase 2 | Heart Failure With Preserved Ejection Fraction (HFpEF) | - | - |
MEDI0382 100 μg | Phase 2 | Type 2 Diabetes | - | - |
AZD5004 | Phase 2 | Obesity or Overweight | - | - |
AZD2171 | Phase 2 | Gastrointestinal Stromal Tumors | - | - |
AZD9291 | Phase 2 | Non-Small Cell Lung Cancer | - | - |
AZD6244 | Phase 2 | Metastatic Colorectal Cancer | - | - |
AZD1305 | Phase 2 | Left Ventricle Function | - | - |
AZD3355 | Phase 2 | Reflux Episodes | - | - |
AZD4831 | Phase 2 | Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis | - | - |
MEDI-546 | Phase 2 | Systemic Lupus Erythematosus | - | - |
AZD4604 | Phase 2 | Asthma | - | - |
Ciclesonide HFA | Phase 2 | Rhinitis, Allergic, Seasonal | - | - |
AZD4877 | Phase 2 | Bladder Cancer | - | - |
AZD9773 | Phase 2 | Severe Sepsis | - | - |
AZD0305 | Phase 2 | Multiple Myeloma | - | - |
AZD1656 | Phase 2 | Type II Diabetes | - | - |
CIN-107 2 mg dosing | Phase 2 | Primary Aldosteronism | - | - |
AZD2423 | Phase 2 | Chronic Obstructive Pulmonary Disease | - | - |
AZD2066 | Phase 2 | Pain | - | - |
AZD4573 | Phase 2 | Relapsed/Refractory Peripheral T-cell Lymphoma | - | - |
[18F]AZD4694 | Phase 2 | Alzheimer's Disease | - | - |
CP-675,206 (Tremelimumab) | Phase 2 | Colorectal Neoplasms | - | - |
AZD1222 | Phase 2 | COVID-19 | - | - |
AZD9668 | Phase 2 | Chronic Obstructive Pulmonary Disease (COPD) | - | - |